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The aim of this study was to develop quantitative real-time (q)PCR assays to detect all known
haemoplasma species, and a human housekeeping gene in order to demonstrate both successful
DNA extraction from clinical samples and to test for sample inhibition, and to apply these qPCRs
to human blood samples and blood smears. Sensitive and specific generic haemoplasma qPCR
assays were developed to amplify haemoplasma species, as well as human glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) as an internal amplification control. An optimized technique
for extracting DNA from stained blood smears was also developed. These methods were applied
to anonymized blood samples obtained from 100 human immunodeficiency virus (HIV)-infected
South Africans and 920 UK patients undergoing haematological examination, and to 15 blood
smears recruited from previous studies describing human haemoplasmosis. Human GAPDH
levels were acceptable in all but three of the blood samples and all but two of the blood smears.
The latter could have arisen due to DNA degradation due to the old age (over 35 years) of these
smears. Haemoplasma infection was found in one HIV-infected South African, but the species
could not be characterized due to the very low levels of DNA present. This report describes novel
extraction and qPCR methodologies for haemoplasma screening. Previously reported human
haemoplasmosis based on cytological diagnosis alone should be viewed with caution.
INTRODUCTION
Haemotropic mycoplasmas (‘haemoplasmas’) are wall-less
erythrocytic bacteria that have not yet been cultured in
vitro. Haemoplasmas are classified within the genus
Mycoplasma based on 16S rRNA gene and RNase P RNA
gene phylogeny (Neimark et al., 2001, 2002; Peters et al.,
2008b). They are divided, based on phylogeny (rather than
pathogenicity or host specificity), into two groups: a
haemominutum group and a haemofelis group (Peters
et al., 2008b; Tasker et al., 2003c). Haemoplasmas have
been identified in many domestic and wild animal species
and can cause haemolytic anaemia (Barker et al., 2010;
Hoelzle, 2008; Hofmann-Lehmann et al., 2004; Neimark
et al., 2002, 2004; Stoffregen et al., 2006; Willi et al., 2007).
Diagnosis of haemoplasmosis in animals has historically
relied on cytology, but the observation of organisms on
erythrocytes in blood smears is known to be unreliable
compared to PCR. In particular, sensitivity is very poor
ranging from 0 to 37.5% (Bauer et al., 2008; Tasker, 2010;
Tasker et al., 2003b; Westfall et al., 2001). Although
specificity is higher, with values of 84–98% reported, it
must be noted that these figures are based upon ex-
perienced board-certified veterinary clinical pathologists
interpreting blood smears and that lower specificity is
common when smears are examined by individuals lacking
experience in haemoplasma diagnosis (Bauer et al., 2008;
Tasker, 2010; Tasker et al., 2003b). PCR is now the
preferred method of diagnosis (Peters et al., 2008a).
Human haemoplasma-like infections have been reported,
although descriptions of diagnostic methods used and
correlation with clinical disease have been poor. Human
haemoplasmosis has been reported in association with
Abbreviations: Ct, threshold cycle; GAPDH, glyceraldehyde-3-
phosphate dehydrogenase; qPCR, quantitative real-time PCR.
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021691 G 2010 SGM Printed in Great Britain 1285systemic lupus erythematosus in the USA (Kallick et al.,
1972) and Croatia (Bosnic et al., 2010), in AIDS patients in
Brazil (Duarte et al., 1992), in sick hospitalized patients in
Niger, Africa (Gre ´tillat & Konarzewski, 1978), in humans
from Inner Mongolia (Yang et al., 2000), in a patient with
neoplasia in the UK (Clark, 1975) and in a patient with
infectious mononucleosis in Yugoslavia (Puntaric et al.,
1986), but in all cases diagnosis was based primarily on
cytology. Other cytological reports of human haemotropic
infections (Archer et al., 1979; Dooley, 1980; Kallick et al.,
1980; Puntaric et al., 1994) are thought unlikely to reflect
haemoplasmosis due to a lack of mycoplasmal morpho-
logical features in the bacteria.
Recently, PCR has been used to detect human haemoplasma
infection. Although twostudies didnotgivefull descriptions
of the origins of the samples analysed or PCR methods used
(Hu et al., 2009; Yang et al., 2007), more thorough des-
criptions have been made by Yuan et al. (2007, 2009), where
PCRdetected thepresence of anorganismverysimilarto the
porcine haemoplasma Mycoplasma suis in people in China,
although clinical haemoplasmosis was not common. In
another study, PCR detected Mycoplasma haemofelis-like
DNA in the blood of a Brazilian with human immunodefi-
ciency virus (HIV) (dos Santos et al., 2008), although the
clinical significance of infection was not discussed. These
reports imply the existence of zoonotic haemoplasma
infections.
PCR studies describing human haemoplasmosis have used
assays designed to amplify a single animal haemoplasma
species but it is possible that people can be infected with
as-yet-unidentified haemoplasma species. One group has
applied a ‘universal’ haemoplasma PCR assay to 414 human
blood samples, but no positive results were obtained and the
lack of an internal amplification control hindered inter-
pretation of negative results (Willi et al., 2009).
The aim of this study was to develop quantitative real-time
(q)PCR assays to detect all known haemoplasma species,
and a human housekeeping gene in order to demonstrate
both successful DNA extraction from clinical samples and
to test for sample inhibition. These assays were applied to
DNA isolated from 15 blood smears recruited from studies
previously documenting suspected human haemoplasma
cytology (Clark, 1975; Gre ´tillat & Konarzewski, 1978; Yang
et al., 2000), and blood samples from over 1000 humans in
the UK and South Africa.
METHODS
Primer and probe design. Nearly full-length 16S rRNA gene
sequences (equivalent to bases 81–1370 of M. haemofelis sequence
accession number U95297) for the haemoplasma species were
downloaded from GenBank (http://www.ncbi.nlm.nih.gov/genbank/)
and aligned using DS Gene 1.5 (Accelrys). From the alignment a
consensus sequence was created for each of the two haemoplasma
groups (Peters et al., 2008b; Tasker et al., 2003c) and used to design
primers and probes for two generic haemoplasma qPCRs: one
for the haemofelis group and one for the haemominutum
group (Primer3Plus; http://www.bioinformatics.nl/cgi-bin/primer3plus/
primer3plus.cgi) (Untergasser et al., 2007). Each of the two haemo-
plasma group consensus sequences was then aligned against other
Mycoplasma species which were closely related by 16S rRNA gene
phylogeny [Mycoplasma fastidiosum (AF125878), Mycoplasma penetrans
(BA000026), Mycoplasma iowae (U29676), Mycoplasma pirum
(M23940), Mycoplasma gallisepticum (AE015450), Mycoplasma pneumo-
niae (U00089) and Mycoplasma genitalium (L43967)] (Peters et al.,
2008b) and assays with primer and probe sequences which had base
mismatches (Table 1) against these non-target species were selected
for use.
To confirm the presence of amplifiable DNA in the extracted human
samples, an assay was designed to detect the human glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) gene (NM_002046) using
Primer3Plus and the same design criteria described above.
Blood samples and DNA extraction. Aliquots of surplus EDTA
blood from 920 samples submitted to the Haematology service at the
Bristol Royal Infirmary, Bristol, UK, and from 100 South African
women infected with HIV [some of whom had been previously tested
for other infectious agents (Pretorius et al., 2004)] were obtained. All
samples were anonymized prior to analysis and were approved by the
local research ethics committees (National Health Service National
Research Ethics Service and University of the Free State).
DNA was extracted from 100 ml EDTA blood using either the DNeasy
Blood kit (Qiagen) or the Macherey-Nagel NucleoSpin Blood kit
(ABgene) as per the manufacturer’s protocol. The DNA was eluted
with 100 ml elution buffer. Positive controls of mixed cat blood
containing the three feline haemoplasma species (M. haemofelis,
‘Candidatus Mycoplasma haemominutum’ and ‘Candidatus
Mycoplasma turicensis’) and a human DNA sample obtained from
a mouth swab, and a negative control blood sample obtained from a
specific-pathogen-free cat, were included in each DNA extraction run.
Blood smears and DNA extraction. Samples were recruited from
three previously reported studies (Clark, 1975; Gre ´tillat &
Konarzewski, 1978; Yang et al., 2000) that had documented human
haemoplasma infection based on cytological examination of blood
smears. Whole blood samples were no longer available but preserved
(methanol-fixed) blood smears were kindly donated by colleagues
(Drs Clark and Yun and Dr Gre ´tillat’s family). Four smears stained
with Wright–Giemsa were obtained from the study describing
haemoplasmosis in humans from Inner Mongolia, China (Yang
et al., 2000), eight smears (one stained with Jenner–Giemsa and seven
unstained) were obtained from the patient with malignant melanoma
and suspected haemoplasmosis described in the Clark (1975) study
and three smears stained with May Gru ¨nwald–Giemsa were obtained
from patients in Niger, Africa (Gre ´tillat & Konarzewski, 1978).
Feline blood smears that had been made in previous studies from
haemoplasma-infected (n572) and non-infected (n512) blood of
known haemoplasma copy number ml
21 (calculated by qPCR)
(Tasker et al., 2006a, b) were available for optimization of the DNA
extraction technique and evaluation of any effect of staining. Thus
haemoplasma copy number values (ml blood)
21 were available for all
of the feline haemoplasma-infected blood samples that had been used
to make the blood smears. Evaluation of any effect of staining on
DNA extraction and subsequent PCR was investigated by staining
several feline blood smears with Wright–Giemsa, Jenner–Giemsa,
Giemsa or May Gru ¨nwald–Giemsa stains (six of each) and comparing
results to those obtained from unstained blood smears.
A number of methods were tried (20 smears per method) to remove
the blood from the slides for DNA extraction: use of a scalpel
(Aubouy & Carme, 2004) or slide scraper (Sykes et al., 2008), as
previously described, and use of a sterile swab moistened in PBS
S. Tasker and others
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scraper made it difficult to remove all of the blood from the slide and
concern regarding laboratory contamination arose due to blood
smear material becoming airborne during removal, so an optimized
method using a swab moistened in PBS was used for further studies.
Following removal of material from the slide, the swab was placed
into a 2 ml tube containing 200 ml PBS, 200 ml Buffer BQ1 (ABgene)
and 25 ml proteinase K (0.56 mg per reaction). The tube was then
incubated in a shaker (Vortemp 56; Labnet) at 70 uC and 1000 r.p.m.
for 15 min (overnight incubation did not improve DNA yield; data
not shown). Ethanol (100%; 210–250 ml) was then added to the tube,
mixed and the solution was transferred to a spin column. Thereafter,
the manufacturer’s instructions (Nucleospin Blood kit) were
followed, and the DNA was eluted with 100 ml elution buffer. The
DNA was stored at 220 uC until use. Positive control blood smears,
obtained from cats infected with either M. haemofelis or ‘Candidatus
M. haemominutum’, and negative control blood smears, obtained
from specific-pathogen-free cats, were included in each DNA
extraction run.
qPCR. The generic haemoplasma and human GAPDH qPCRs were
performed using Qiagen HotStarTaq Master Mix with 200 nM of
each primer, 100 nM of each probe or SYBR Green 1 (1:100000 final
dilution; used for validation of the primers) (Sigma-Aldrich), 4.5 mM
MgCl2 and 5 ml DNA in a total volume of 25 ml. The extraction
control samples described above, as well as positive control samples of
feline haemoplasma DNA of known copy number and a negative
control (water), were included in each PCR run applied to DNA from
blood samples and blood smears.
All qPCRs were performed in an iCycler iQ (Bio-Rad Laboratories)
with an initial incubation of 95 uC for 15 min and then 45 cycles of
95 uC for 10 s and 60 uC (haemofelis and haemominutum group
qPCRs) or 57.5 uC (GAPDH qPCR) for 30 s during which the
fluorescence data were collected. The thermocycling protocol was
extended when SYBR Green I was used by heating the samples from
75 uCt o9 5uCi n0 . 5uC increments with a dwell time at each
temperature of 15 s during which fluorescent data were collected to
create a melting curve. The melting temperatures of the products
were determined with the iCycler iQ Optical System Software (v3.1;
Bio-Rad Laboratories). During the optimization of the assays,
reaction products from the sequence-specific plasmids and feline
blood samples infected with the three feline haemoplasma species
(Peters et al., 2008a), as well as the mouth swab, were separated by
2% agarose gel electrophoresis, using ethidium bromide stain, with
5 ml EasyLadder I (Bioline) and the GelDoc-It Imaging System
(UVP) used to confirm that a single amplicon of the correct size
(114 bp for the haemofelis group qPCR and 139 bp for the
haemominutum group qPCR) was produced. Previously sequenced
plasmids containing the 16S rRNA gene from M. haemofelis and
‘Candidatus M. haemominutum’ (Tasker et al., 2003a) were used to
test the efficiency and sensitivity of the qPCRs. A 10-fold serial
dilution of each plasmid (range: 1–10
7 copies per reaction) in
triplicate was used for each of the two generic haemoplasma group-
specific assays. Specificity of the assays was assessed using DNA
from haemoplasma species (M. haemofelis, Mycoplasma haemocanis,
‘Candidatus M. turicensis’, Mycoplasma coccoides,‘ Candidatus M.
haemominutum’, ‘Candidatus Mycoplasma haematoparvum’, M.
suis,‘ Candidatus Mycoplasma haemolamae’, Mycoplasma wenyonii
and Mycoplasma haemomuris) either obtained from a previous
study (Peters et al., 2008b) or kindly donated by Drs Rikihisa and
Messick, and non-target Mycoplasma species (M. fastidiosum, M.
penetrans, M. iowae, M. pirum, M. gallisepticum, M. pneumoniae and
M. genitalium) kindly provided from the Mycoplasma culture
collection at the Veterinary Laboratories Agency (Weybridge,
Surrey, UK).
A dilution of human genomic DNA obtained from a mouth swab (10-
fold dilutions over 6 orders of magnitude) was used to assess the
reaction efficiency of the human GAPDH qPCR.
For evaluation and optimization of the blood smear extraction
method, DNA extracted from the feline blood smears was subjected to
each of the two new haemoplasma haemofelis and haemominutum
group-specific qPCRs described above, as well as to the previously
described qPCR assays duplexed for either M. haemofelis or
‘Candidatus M. haemominutum’ and feline 28S rDNA (Peters et al.,
2008a) using 5 ml extracted DNA per PCR. This enabled comparison
of different extraction methods by comparing haemoplasma and 28S
rDNA via threshold cycle (Ct) values. These results obtained on blood
smears were also compared with the known contemporaneous
haemoplasma copy numbers in the feline blood used to make the
smears, taking into account the volume of blood used to make a
blood smear (approx. 5 ml), to allow a measure of DNA recovery from
the blood smear to be made. Any qPCR inhibitory effects of staining
were also assessed by incorporation (‘spiking’) of a defined amount of
a synthetically constructed reference plasmid, based on feline herpes
virus, into the PCR mastermix, adding 5 ml of the extracted DNA
from stained smears or water, and subjecting to a qPCR specific for
the reference plasmid (data not shown; further information may be
available from the corresponding author). The Ct values obtained
using water were then compared to those obtained in the presence of
DNA extracted from stained smears to determine the presence of PCR
inhibition.
Acceptable human GAPDH qPCR Ct values were defined as those
¡30 on the blood samples and those ¡33 on blood smears, based on
previous work with internal amplification controls (Tasker et al.,
2009).
RESULTS
Generic haemoplasma assay optimization
The generic haemoplasma haemofelis and haemominutum
group-specific qPCRs primer and probe sequences are
shown in Tables 1 and 2.
The assays, when run with SYBR Green I and DNA from
feline blood infected with each of the feline haemoplasma
species,produceda singlemeltpeakanda singleampliconof
expected size (114 bp for the haemofelis group qPCR and
139 bp for the haemominutum group qPCR) when
separated by agarose gel electrophoresis (data not shown).
The reaction efficiencies of the haemofelis group and
haemominutum group assays were both in excess of 97%
(Table 2) and were able to detect between 1 (1/3 replicates)
and 10 (3/3 replicates) plasmid copies per PCR. Of the
haemoplasma species tested, the haemominutum group
assay only detected ‘Candidatus M. haemominutum’,
‘Candidatus M. haematoparvum’, M. suis,‘ Candidatus M.
haemolamae’ and M. wenyonii. The haemofelis group assay
was able to detect M. haemofelis,‘ Candidatus M. turicensis’,
M. haemocanis,M.coccoidesand M. haemomuris, all members
of the haemofelis group. However, ‘Candidatus M. haemo-
minutum’ and ‘Candidatus M. haematoparvum’, both
members of the haemominutum group, were also amplified
by this qPCR, but much less efficiently (Ct values were
approximately three to four cycles later than those obtained
with the haemominutum group assay). No cross-reactivity of
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in non-target haemoplasma and Mycoplasma species
Dashes indicate identical bases with base differences indicated by the appropriate letter. The Y base in the probe for the haemofelis group assay
indicated either a C or T base at this position. The orientation of the primers and probe is indicated for the appropriate sequences, i.e. 59–39 for the
forward primer and sense probe and 39–59 for the reverse primer or antisense probe.
Haemofelis group 16S rRNA gene
assay
Forward primer (5§–3§) Sense probe (5§–3§) Reverse primer (3§–5§)
Haemofelis group sequences
M. haemofelis GGAGCGGTGGAATGTGTAG TYAAGAACACCAGAGGCGAAGGCG CGTTTACCCTAATCTATGGGG
M. haemocanis ------------------- ------------------------ ---------------------
M. haemomuris ------------------- ------------------------ ---------------------
‘Candidatus M. turicensis’ ------------------- ------------------------ ---------------------
M. coccoides ------------------- ------------------------ ---------------------
Haemominutum group sequences
‘Candidatus M. haemominutum’ -T------------C---- -G-G-------------T------ ---------------------
‘Candidatus M. haematoparvum’ -T------------C---- -G-G-------------T------ ---------------------
M. suis -T—T---------AC---- -G-G-------------T------ ---------------------
M. wenyonii -T------------C---- -G-G-------------T------ ---------------------
M. ovis -T------------C---- -G-G-------------T------ ---------------------
‘Candidatus Mycoplasma
haemodidelphidis’
-T—T---------AC---- -G-G--------A-------A--A ---------------------
‘Candidatus M. haemolamae’ -T------------C---- -G-G-------------T------ ---------------------
‘Candidatus Mycoplasma kahanei’ ----T--------AC---- -G-G-------------T------ ---------------------
Other Mycoplasma sequences
M. fastidiosum ---------A----C---- -G-----------T---------- ------T-------------A
M. gallisepticum ---------A----C---- GG---------------------- ------T-------------A
M. genitalium ---------A----C---- GA-G---------T---------- ------T-------------A
M. iowae --------------C---- GG-----------T---------- ------T-------------A
M. penetrans --------------C---- GG---------------------- ------T-------------A
M. pirum ---------G----C---- GG-----------TT--------- ------T-------------A
M. pneumoniae ---------A----C---- GA-G---------T---------- ------T-------------A
Haemominutum group 16S rRNA
gene assay
Forward primer (5§–3§) Antisense probe (3§–5§) Reverse primer (3§–5§)
Haemominutum group sequences
‘Candidatus M. haemominutum’ GGGGCCAAGTCAAGTCATC CCCGACGTTTGCACGATGTTACCAT CTATTTTCCGACGTTAAGCG
‘Candidatus M. haematoparvum’ ------------------- ------------------------- --------------------
M. suis ------------------- ------------------------- --------------------
M. wenyonii ------------------- ------------------------- --------------------
M. ovis ------------------- ------------------------- --------------------
‘Candidatus M. haemodidelphidis’ ------------------- ------------------------- --------------------
‘Candidatus M. haemolamae’ ------------------- ------------------------- --------------------
‘Candidatus M. kahanei’ ------------------- ------------------------- --------------------
Haemofelis group sequences
M. haemofelis ---AT--C----------- -----------------------GC ----CC--------------
M. haemocanis ---AT--C----------- -----------------------GC ----CC--------------
M. haemomuris ---AT--C-----A----- ----G---------A---------C --------------------
‘Candidatus M. turicensis’ ---AT--C-----A----- ----G---------A---------C --------------------
M. coccoides ---AT--C-----A----- ----G---------A--------C- --------------------
Other Mycoplasma sequences
M. fastidiosum ---ATG-C-----A----- ------------------------A ---AC----------G----
M. gallisepticum ---ATG-C-----A----- ------------ -----------GG ---AC-C-------------
M. genitalium ---ATG-C-----A----- ------------ -----------GG ---AC-C------------A
M. iowae ---ATG-C-----A----- ----G-------------------A ---AC-C-------------
M. penetrans ---ATG-C-----A----- ----G-------------------G ---GC-C------------A
M. pirum ---A-G-C-----A----- ------------ -----------GG ---AC-C-------------
M. pneumoniae ---ATG-C-----A----- ------------ -----------GG ---AC-C------------A
S. Tasker and others
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qPCR with DNA from the non-target Mycoplasma species
tested was observed.
The efficiency of the human GAPDH qPCR assay was over
99% over 6 orders of magnitude (Table 2).
Blood samples
One of the DNA extracts from the 920 UK human blood
samples was negative with the human GAPDH qPCR
whilst the remaining samples had a median Ct of 22 (range
19.3–32.2). Two samples had Ct values .30 (31.9 and
32.2). Thus GAPDH levels were acceptable in all but three
of the 920 blood samples. None of the samples were
positive with either of the two generic haemoplasma
group qPCR assays. Positive and negative extraction and
PCR controls were appropriately positive and negative
throughout.
All 100 samples from HIV-infected South African women
were positive with the GAPDH qPCR (median Ct 24.3;
range 20.7–29.8, thus all ¡30). None of the samples were
positive with the generic haemoplasma haemominutum
group qPCR assay but one sample (no. 153) was positive
with the haemofelis group qPCR assay, with a Ct of 36.5
(this sample had a GAPDH Ct value of 24.4). Positive
and negative extraction and PCR controls were appro-
priately positive and negative throughout. Sample
number 153 underwent repeat generic haemoplasma
haemofelis group qPCR twice more and was positive
both times (Ct values of 39.1 and 37.7). Attempts were
made to amplify and sequence the 16S rRNA and RNase
P genes from the DNA extracted from sample number
153 using PCR as described previously (Peters et al.,
2008b; Tasker et al., 2003c) but these were unsuccessful.
Attempts were also made to concentrate the DNA from
the remaining blood available by repeat extractions and
elution into smaller volumes of buffer before reattempt-
ing amplification and sequencing, but again no sequen-
cing data were generated.
Blood smears
Swabs moistened in PBS to remove the blood smear
material for subsequent DNA extraction gave acceptable
results on qPCR (n520); the Ct values for the feline
haemoplasmas (M. haemofelis or ‘Candidatus M. haemo-
minutum’), and feline 28S rDNA, obtained on fixed but
unstained smears made with feline blood infected with
these species were greater than those obtained on con-
temporaneous blood samples by 3.4–6.8 cycles (median
4.2). This median Ct difference of 4.2 roughly equates to an
18-fold difference in the amount of DNA detected on
blood smears compared with blood samples, which is
approximately that which would be expected if around 5 ml
blood was used to make the blood smear compared with
100 ml used for DNA extraction from whole blood. Stain-
ing of the blood smears with Wright–Giemsa, Jenner–
Giemsa, Giemsa or May Gru ¨nwald–Giemsa stains (n56 for
each stain), and subsequent DNA extraction and qPCR,
resulted in Ct values for feline haemoplasma and 28S rDNA
detection that differed from contemporaneous blood
samples by 2.8–5.7 cycles (median 4.5), showing that the
staining of the blood smears did not have a significant
deleterious effect on either DNA extraction or subsequent
qPCR. Additionally, spiking of the reference plasmid into
the PCRs performed on DNA extracted from blood smears
(n56) did not provide any evidence of PCR inhibitors in
these samples, with similar Ct values obtained for the
reference plasmid whether smear DNA was present or not
(data not shown).
All 15 blood smear samples that had been recruited from
three previously reported human haemoplasma studies
(Clark, 1975; Gre ´tillat & Konarzewski, 1978; Yang et al.,
2000) gave negative results with the generic haemoplasma
group assays, whilst haemoplasma-infected and uninfected
blood smear extraction and PCR controls gave positive and
negative results, respectively. All 15 blood smear samples
gave positive results with the human GAPDH qPCR assay,
but the Ct values ranged from 25.1 to 38.6 (median 29.2).
Two of the 15 smear samples had human GAPDH Ct values
Table 2. Details of primer and probe sequences used for the detection of haemoplasma species and human GAPDH
Target Forward
primer
Reverse
primer
5§
Fluorophore
Probe 3§
Quencher
Product
size (bp)
% Reaction
efficiency (SD)
R
2
Haemofelis group
16S rRNA gene
GGAGCGGTGG-
AATGTGTAG
GGGGTAT-
CTAATCC-
CATTTGC
FAM TYAAGAACA-
CCAGAGG-
CGAAGGCG
BHQ-1 114 100.5 (1.2) 0.99
Haemominutum
group 16S rRNA
gene
GGGGCCAAGT-
CAAGTCATC
GCGAATT-
GCAGCC-
TTTTATC
FAM TACCATTGT-
AGCACGTT-
YGCAGCCC
BHQ-1 139 97.4 (1.9) 0.99
Human GAPDH
gene
GAGTCAACGG-
ATTTGGTCGT
AATGAAG-
GGGTCAT-
TGATGG
Texas Red CAGGGCTGC-
TTTTAACTC-
TGGCAAAG-
TGGA
BHQ-2 95 99.7 (0.4) 0.99
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from the Clark (1975) study (Ct values of 33.1 and 38.6).
DISCUSSION
This report describes the development and application of
generic qPCR assays, incorporating TaqMan probes, for the
detection of haemoplasmas in human blood samples and
blood smears. The high sensitivity and specificity of these
assays make them ideal for screening large numbers of
human samples. Of the 920 UK samples, 917 gave
acceptable results (Ct ¡30) with the human GAPDH
qPCR assay, but none of these were qPCR-positive for
haemoplasmas. Since these samples were anonymized, we
were unaware of what proportion of the samples were
taken from anaemic or immunocompromised patients,
which are thought to be at a higher risk of having
haemoplasma infection (dos Santos et al., 2008; Willi et al.,
2009). It is possible that the individuals sampled were not
at high risk for haemoplasma infection.
Since M. haemofelis-like infection has been detected by
PCR in the blood of an HIV-infected Brazilian man (dos
Santos et al., 2008), we sought to obtain blood samples
from HIV-infected patients as we felt that such a group
would comprise people at a higher risk of haemoplasma
infection. Despite analysing 100 blood samples from South
African women infected with HIV, only one sample gave a
positive result with the generic haemofelis group qPCR.
Unfortunately, the Ct value indicated a very low level of
haemoplasma DNA in this sample and attempts to further
characterize the haemoplasma species failed. Since all
extraction and PCR negative controls were appropriately
negative in the study, we believe that the positive result
reflects infection with a haemoplasma species. Unfortu-
nately, anonymization of the samples meant that we were
unable to resample this patient.
The inclusion of the human GAPDH internal amplification
control in this qPCR study enables us to be confident that
amplifiable DNA was present in the majority of haemoplasma
qPCR-negative samples; thus the negative haemoplasma
qPCR results obtained are less likely to reflect problems with
DNA extraction, PCR inhibition or operator error.
The development and optimization of a DNA extraction
technique for the extraction of DNA from blood smears
enabled us to analyse smears preserved from previous
studies of suspected human haemoplasma infection (Clark,
1975; Gre ´tillat & Konarzewski, 1978; Yang et al., 2000).
Despite acceptable amounts of GAPDH gene amplification
from the majority (13/15) of these smears, no evidence of
haemoplasma infection was detected by qPCR. Before the
smears underwent DNA extraction, they were examined by
light microscopy (S.T./H.N., data not shown) but no
evidence of haemoplasma-like bodies was seen; when
epierythrocyte-like structures were visible, these resembled
stain precipitate or crenated edges of red blood cells. It is
well known that cytology for the diagnosis of haemoplasma
infection can have both poor specificity and sensitivity, and
cytology is no longer recommended as a diagnostic method
for haemoplasmosis due to its unreliability (Bauer et al.,
2008; Tasker et al., 2003b; Westfall et al., 2001). The results
of this study support this, and strongly suggest that
previous reports of human haemoplasmosis should be
viewed with caution if the diagnosis was based on cytology
alone without molecular confirmation. The smears in the
current study that generated unacceptable levels of human
GAPDH PCR product (Ct .33) could have yielded false-
negative results with the haemoplasma qPCRs due to DNA
extraction failure, damaged DNA, PCR inhibition or
operator error. Indeed, DNA degradation was thought to
be a possible problem when dealing with such old blood
smears. It is encouraging, therefore, that acceptable amounts
of human DNA were amplifiable from most of the blood
smears, and it is of note that the two smears from which
unacceptable amounts of human DNA were recovered were
over 35 years old (Clark, 1975). Nevertheless, at least two
smears from the same study (Clark, 1975) gave acceptable
human GAPDH Ct values with concurrent negative
haemoplasma qPCR results; since all of the smears from
this study were derived from one patient, we believe that this
patient showed no evidence of haemoplasmosis.
Our method for DNA extraction from blood smears offers
a valuable tool for future PCR studies on suspected cases
for which only blood smears are available. Optimization
of the technique had to be based on the amplification of
feline haemoplasmas and a feline 28S rDNA internal
control, rather than human equivalents, due to the lack of
haemoplasma-positive human samples. The median Ct
difference between the blood smears and contemporaneous
blood samples equated approximately to that expected
from the different volumes of blood used for extraction.
However, the precise volume of blood used to make blood
smears will vary from smear to smear as will the number of
nucleated cells present in the smears (from which the
GAPDH gene is amplified). These variations are likely to
contribute to the greater Ct differences identified for some
samples during optimization.
These generic haemoplasma qPCR assays will be extremely
useful for the detection of previously recognized haemo-
plasma species in samples, as well as the identification of
novel haemoplasma species. A degree of cross-reactivity
was detected between members of the haemominutum
group and the haemofelis assay, although the Ct values
obtained were later than with the group-specific assay. This
cross-reactivity was not seen with all the samples from the
haemominutum group that were used in the optimization
and this is likely due to the number of haemoplasma copies
present in the clinical samples that were available for
testing. The cross-reactivity was not considered problem-
atic as the intention of the study was to develop qPCRs that
could be used to screen samples for any haemoplasma
species. Indeed, very recently, both assays have been
successfully used to identify novel haemoplasma species
in rodents and primates, results for which will be presented
S. Tasker and others
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produce only small PCR products, samples identified by
this method require further characterization by amplifica-
tion and sequencing of larger PCR products from the 16S
rRNA gene and, preferably, an additional gene such as
RNase P. However, as described in this report for sample
number 153, further characterization may be limited by
low levels of haemoplasma DNA. The inclusion of the
human GAPDH gene qPCR helps validate negative results
obtained in human samples. We found very little evidence
of human haemoplasmosis in the samples screened in the
current study, and previously reported cases of human
haemoplasmosis based on cytology alone should be viewed
with caution. However, recent reports of molecular
evidence of human haemoplasma infection (Hu et al.,
2009; dos Santos et al., 2008; Yang et al., 2007), together
with very recent findings from our laboratory using the
described generic assay, strongly indicate that the search for
haemoplasmosis in people should continue using reliable
molecular techniques such as the qPCR assays described
here, so that the significance of human haemotropic
mycoplasma infections can be more accurately defined.
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